Ever Source Wealth Advisors, LLC Biotechnology

Ever Source Wealth Advisors, LLC

$1.95 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EWTX Edgewise Therapeutics, Inc.	$1.16B	$0 0.0% of portfolio	61	Q2 2025 New
HOWL Werewolf Therapeutics, Inc.	$37.2M	$0 0.0% of portfolio	167	Q2 2025 Added 377.14%
VALN Valneva Se	$631M	$0 0.0% of portfolio	93	Q2 2025 New
CNTA Centessa Pharmaceuticals PLC	$2.3B	$0 0.0% of portfolio	20	Q2 2025 New
NAUT Nautilus Biotechnology, Inc.	$172M	$0 0.0% of portfolio	378	Q2 2025 Added 160.69%
MOLN Molecular Partners Ag	$120M	$0 0.0% of portfolio	41	Q2 2025 New
VERV Verve Therapeutics, Inc.	$667M	$0 0.0% of portfolio	3	Q2 2025 Reduced 99.43%
IPSC Century Therapeutics, Inc.	$34.7M	$0 0.0% of portfolio	455	Q2 2025 Added 1,009.76%
ELEV Elevation Oncology, Inc.	$8.39M	$0 0.0% of portfolio	56	Q2 2025 Added 194.74%
ABOS Acumen Pharmaceuticals, Inc.	$87.5M	$0 0.0% of portfolio	415	Q2 2025 Reduced 14.61%
TCRX T Scan Therapeutics, Inc.	$37.1M	$0 0.0% of portfolio	70	Q2 2025 Added 233.33%
ABSI Absci Corp	$399M	$0 0.0% of portfolio	210	Q2 2025 Added 62.79%
CRBU Caribou Biosciences, Inc.	$146M	$0 0.0% of portfolio	549	Q2 2025 Reduced 9.85%
ADGI Adagio Therapeutics, Inc.	$505M	$0 0.0% of portfolio	109	Q2 2025 Reduced 82.48%
ELYM Eliem Therapeutics, Inc.	$109M	$0 0.0% of portfolio	51	Q2 2025 Added 466.67%
TYRA Tyra Biosciences, Inc.	$657M	$0 0.0% of portfolio	40	Q2 2025 Added 344.44%
PYXS Pyxis Oncology, Inc.	$125M	$0 0.0% of portfolio	591	Q2 2025 Added 22.11%
TRDA Entrada Therapeutics, Inc.	$218M	$0 0.0% of portfolio	7	Q2 2025 New
SLN Silence Therapeutics PLC	$257M	$0 0.0% of portfolio	10	Q2 2025 New
LGVN Longeveron Inc.	$4.86M	$0 0.0% of portfolio	481	Q2 2024 New
PBYI Puma Biotechnology, Inc.	$233M	$0 0.0% of portfolio	161	Q2 2025 Added 2,583.33%
AMLX Amylyx Pharmaceuticals, Inc.	$895M	$0 0.0% of portfolio	25	Q4 2024 New
VERA Vera Therapeutics, Inc.	$796M	$0 0.0% of portfolio	6	Q2 2025 New
NVCT Nuvectis Pharma, Inc.	$88.1M	$0 0.0% of portfolio	96	Q2 2025 New
THRD Third Harmonic Bio, Inc.	$217M	$0 0.0% of portfolio	50	Q2 2025 New
ATOS Atossa Therapeutics, Inc.	$113M	$0 0.0% of portfolio	221	Q2 2025 Added 110.48%
SRPT Sarepta Therapeutics, Inc.	$2.04B	$0 0.0% of portfolio	14	Q2 2025 Reduced 89.47%
MGNX Macrogenics Inc	$95.9M	$0 0.0% of portfolio	47	Q2 2025 Reduced 27.69%
CRMD Cor Medix Inc.	$467M	$0 0.0% of portfolio	11	Q2 2025 Added 175.0%
ATNM Actinium Pharmaceuticals, Inc.	$35.3M	$0 0.0% of portfolio	215	Q2 2025 Added 27.98%
OCUL Ocular Therapeutix, Inc	$919M	$0 0.0% of portfolio	78	Q2 2025 Added 105.26%
XENE Xenon Pharmaceuticals Inc.	$2.66B	$0 0.0% of portfolio	26	Q2 2025 Reduced 55.17%
VNDA Vanda Pharmaceuticals Inc.	$244M	$0 0.0% of portfolio	110	Q2 2025 New
MDXG Mimedx Group, Inc.	$838M	$0 0.0% of portfolio	8	Q2 2025 New
CLLS Cellectis S.A.	$152M	$0 0.0% of portfolio	13	Q1 2023 New
XBIT X Biotech Inc.	$71.5M	$0 0.0% of portfolio	31	Q2 2025 Added 138.46%
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	10	Q2 2025 Reduced 28.57%
ABUS Arbutus Biopharma Corp	$726M	$0 0.0% of portfolio	169	Q2 2025 Added 106.1%
AVXL Anavex Life Sciences Corp.	$626M	$0 0.0% of portfolio	78	Q2 2025 Added 136.36%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.